Youngkee Shin

17PUBLICATIONS
22CO-AUTHORS
Oncology and carcinogenesis not elsewhere classifiedEnvironmental epidemiologyMedical infection agents (incl. prions)Cancer therapy (excl. chemotherapy and radiation therapy)Pharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Apr 09, 2025
Erratum: Non-canonical Function of Prolyl Hydroxylase Domain 2 in Breast Cancer Cell Growth and Progression: Role of Peptidyl-prolyl Cis-trans Isomerase NIMA-interacting 1.

Yanymee N Guillen-Quispe, Su-Jung Kim, Soma Saeidi

|Jan 10, 2025
Non-canonical Function of Prolyl Hydroxylase Domain 2 in Breast Cancer Cell Growth and Progression: Role of Peptidyl-prolyl Cis-trans Isomerase NIMA-interacting 1.

Yanymee N Guillen-Quispe, Su-Jung Kim, Soma Saeidi

|Nov 11, 2024
Granzyme mRNA-miRNA interaction and its implication to functional impact.

Hyeon-Young Kim, Jung-Min Kim, Young Kee Shin

|Feb 11, 2023
Modulating Glycolysis to Improve Cancer Therapy.

Chaithanya Chelakkot, Vipin Shankar Chelakkot, Youngkee Shin

|Jan 12, 2023
Pretreatment of rhesus monkeys with transdermal patches containing physostigmine and procyclidine: implications of the delivery system for the potential application against VX nerve agent intoxication in humans.

Ji-Hye Nam, Min-Soo Kim, Young-Jo Song

|Jun 09, 2022
SMAD4 Controls Cancer Cell Metabolism by Regulating Methylmalonic Aciduria Cobalamin Deficiency (cbl) B Type.

Kyoung Song, Hun Seok Lee, Lina Jia

Pageof 3

Frequent Collaborators

4 joint publications

Kyoung Song

3 joint publications

Nirmal Rajasekaran

2 joint publications

Woo Sung Son

2 joint publications

Chaithanya Chelakkot